Wellington Management Group LLP filed Amendment No. 2 to its Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of AtriCure, Inc. common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: Wellington Management Group LLP reported beneficial ownership of 4,116,204 shares of AtriCure, Inc. common stock, representing 8.1% of the class.
  • No sole voting or dispositive power: The filing disclosed 0 shares held with sole voting power and 0 shares held with sole dispositive power across all reporting entities.
  • Shared voting power: Wellington Management Group LLP, Wellington Group Holdings LLP, and Wellington Investment Advisors Holdings LLP each reported shared voting power over 2,290,789 shares.
  • Shared dispositive power: The same three entities each reported shared dispositive power over 4,116,204 shares.
  • Wellington Management Company LLP stake: As a subsidiary investment adviser, Wellington Management Company LLP reported shared dispositive power over 3,464,125 shares, representing 6.8% of the class.
  • Event date: The date of the event requiring this filing was September 30, 2026.

Wellington Management Discloses Ownership Structure in AtriCure Common Stock

According to the filing, four entities within the Wellington Management organization are named as reporting persons: Wellington Management Group LLP (organized in Massachusetts), Wellington Group Holdings LLP (Delaware), Wellington Investment Advisors Holdings LLP (Delaware), and Wellington Management Company LLP (Delaware). All four entities share a principal business address at c/o Wellington Management Company LLP, 280 Congress Street, Boston, MA 02210. The issuer, AtriCure, Inc., is headquartered at 7555 Innovation Way, Mason, OH 45040, and its common stock carries CUSIP number 04963C209. The filing is listed on NASDAQ:ATRC.

The filing states that the securities reported are "owned of record by clients of one or more investment advisers identified in Item 7 directly or indirectly owned by Wellington Management Group LLP," and that those clients "have the right to receive, or the power to direct the receipt of, dividends from, or the proceeds from the sale of, such securities." The filing further states that no single client is known to hold such rights with respect to more than five percent of the class. Wellington Management Group LLP is classified as a holding company (HC), while Wellington Management Company LLP is classified as an investment adviser (IA).

The certification included in the filing states that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities." The filing was signed by Matthew Revell on behalf of Wellington Management Group LLP.

What Was Disclosed

Wellington Management Group LLP filed Amendment No. 2 to Schedule 13G disclosing aggregate beneficial ownership of 4,116,204 shares, or 8.1%, of AtriCure, Inc. common stock as of September 30, 2026, held through affiliated holding companies and investment advisers with no sole voting or dispositive power reported.